Retraction
Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation
Paper Information
Record ID:
48564
Author(s):
Publication Date:
September 25, 2022
Retraction Date:
August 02, 2023
(2.3 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9871939Additional Notes:
See also: https://pubpeer.com/publications/1AAF0809CE5EEA51E00C79E05ABC8F
Citations (7)
7
Total Citations3
Post-Retraction(42.9%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
421
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Unveiling the antitumor synergy between pazopanib and metformin on lung cancer through suppressing p-Akt/ NF-κB/ STAT3/ PD-L1 signal pathway
Fatma Abdallah, Asser I. Ghoneim, Mohammad M. Abd‐Alhaseeb et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2024
4 citations
4 citations
421 days after retraction
Anticarcinogenic Effects of Gold Nanoparticles and Metformin Against MCF-7 and A549 Cells
Ali Yeşildağ, Halime Topal Kızıloğlu, Ebubekir Dirican et al. (6 authors)
Biological Trace Element Research
Open Access
Published: Feb 2024
7 citations
7 citations
197 days after retraction
Low glucose availability potentiates the effects of metformin on model T cell activation and exhaustion markers in vitro
Jernej Repas, Lea Peternel, Harald Sourij et al. (4 authors)
Frontiers in Endocrinology
Open Access
Published: Dec 2023
6 citations
6 citations
125 days after retraction
The Metformin Immunoregulatory Actions in Tumor Suppression and Normal Tissues Protection
Jitendra Gupta, Abduladheem Turki Jalil, Zahraa Hamzaa Abd Alzahraa et al. (8 authors)
Current Medicinal Chemistry
Published: Jul 2023
1 citation
1 citation
28 days before retraction
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
Mohamad Ali Hijazi, André Gessner, Nahed El‐Najjar
Cancers
Open Access
Published: Jun 2023
17 citations
17 citations
48 days before retraction
Retracted: Metformin Synergizes with PD-L1 Monoclonal Antibody Enhancing Tumor Immune Response in Treating Non-Small Cell Lung Cancer and Its Molecular Mechanism Investigation
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
213 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025